A trial looking at MK-3475A for certain types of lymphoma (MK-3475A-F65)
This trial is looking at a new drug called MK-3475A for lymphoma that has come back or is getting worse despite treatment.
Term used in conjunction with Bloodwise for their definition of cancers of the blood
This trial is looking at a new drug called MK-3475A for lymphoma that has come back or is getting worse despite treatment.
This trial is looking at a blood test to check for signs of a fungal infection before giving an anti fungal medication.
This trial is looking at a different way of giving a combination of drugs called MATRix. It is for people with a primary lymphoma of the brain and spinal cord.
This trial is looking at different types of new medicines to treat B cell non-Hodgkin lymphoma that has come back after treatment or got worse during treatment.
This trial is comparing new combinations of treatment with standard treatment for follicular lymphoma.
This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.
This study is looking at whether diet and exercise can improve the health of people with chronic lymphocytic leukaemia (CLL).
This trial is looking at zilovertamab vedotin by itself or in combination with nemtabrutinib for people with B cell lymphomas and B cell leukaemia.
This trial looked at an immunotherapy drug called magrolimab alone or with azacitidine for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).
This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.